Immuneel

Manufacturing · India · 51-200 Employees

View Company Info for Free

Overview

Headquarters

Mazumdar Shaw Medical Center Narayana Hr...

Phone Number

+91 1149403633

Revenue

$48.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1

About Immuneel

Immuneel Therapeutics is a clinical-stage biotechnology company based in India that focuses on developing and delivering advanced cell and gene therapies, particularly CAR-T cell therapies for cancer treatment. It works on genetically engineered immune cell–based treatments that are designed to recognize and destroy cancer cells, with an emphasis on making these therapies more affordable and accessible within India and other emerging markets. The company integrates research, manufacturing, and clinical collaboration with hospitals to build end-to-end capabilities for producing high-quality immunotherapies, aiming to expand access to cutting-edge cancer care while contributing to the global development of next-generation personalized medicine.Explore more
Immuneel's Social MediaPopular SearchesImmuneel Therapeutics Pvt LtdImmuneel Therapeutics Private LtdImmuneelSIC Code 87,873NAICS Code 32,325Show more

Immuneel Org Chart

Amit Mookim, Chief Executive Officer & Board Director at Immuneel
India flag for contact location.

Chief Executive Officer & Board Director

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
CN
India flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SS
India flag for contact location.

Manager, Commercial

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
KK
India flag for contact location.

Manager, Commercial

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Immuneel your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Immuneel is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Immuneel is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immuneel.

Immuneel financials insights

Gather financial insights about Immuneel, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2024

Series A

$27M

2026

Series B

$10.5M

See All Immuneel's Financials Insights

Immuneel Tech Stack

A closer look at the technologies used by Immuneel

Most Recent Scoops

Funding
Funding
Hiring Plans
Immuneel has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Event
Cloud, Product Marketing, Events, Infrastructure, Engineering, Clinical Systems, Data Management, Data Science, Machine Learning, Sales, Enterprise Software, Software, Bioengineering, Pharmaceuticals, Field /Outside Sales, Artificial Intelligence, Clinical Operations, Field Marketing, Healthcare Technology, Operations
Event
Person-Based
Siddhartha Mukherjee, Co-Founder, appeared on a podcast called "Science Friday" on 08/05/2024. Topics discussed include Cancer treatment, prevention, mortality decline.
Events, Podcast
Funding
See more scoops

Immuneel News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Immuneel

What is Immuneel's official website?
Immuneel's official website is www.immuneel.com
What is Immuneel's Revenue?
Immuneel's revenue is $48.6 Million
What is Immuneel's SIC code?
Immuneel's SIC: 87,873
What is Immuneel's NAICS code?
Immuneel's NAICS: 32,325
How many employees does Immuneel have?
Immuneel has 51-200 employees
What industry does Immuneel belong to?
Immuneel is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Immuneel use?
Some of the popular technologies that Immuneel uses are: Microsoft 365, Daily, Hostgator, Microsoft Exchange Online
Who is the CFO of Immuneel?
Immuneel's CFO is Ca Nanda
How do I contact Immuneel?
Immuneel contact info: Phone number: +91 1149403633 Website: www.immuneel.com
What does Immuneel do?

Immuneel Therapeutics is a clinical-stage biotechnology company based in India that focuses on developing and delivering advanced cell and gene therapies, particularly CAR-T cell therapies for cancer treatment. It works on genetically engineered immune cell–based treatments that are designed to recognize and destroy cancer cells, with an emphasis o... n making these therapies more affordable and accessible within India and other emerging markets. The company integrates research, manufacturing, and clinical collaboration with hospitals to build end-to-end capabilities for producing high-quality immunotherapies, aiming to expand access to cutting-edge cancer care while contributing to the global development of next-generation personalized medicine.Read More

What are Immuneel social media links?
Immuneel Linkedin page
Who invested in Immuneel?
Immuneel has 8 investors including Eight Roads, F-Prime Capital Partners, Eight Roads and True North.
Is Immuneel a public company?
Immuneel is private company therefore does not currently have an official ticker symbol
See more information about Immuneel

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.